The reduced numbers of SCS CD169+ macrophages in LNM may also impair acquisition and presentation of tumor-antigens to follicular dendritic cells (FDCs), B-cells, or interfollicular T-cells, thus leading to a worse prognosis, as demonstrated in several studies [15, 18–21, 27, 47, 48]. Here, SIGLEC1 is linked to neoplasm.